Ischaemic and pharmacological preconditioning is associated with attenuation of p38 MAPK activation during sustained ischaemia and reperfusion

被引:0
|
作者
Lochner, A [1 ]
Marais, E [1 ]
Genade, S [1 ]
Huisamen, B [1 ]
Strijdom, H [1 ]
Moolman, JA [1 ]
机构
[1] Univ Stellenbosch, Fac Hlth Sci, Dept Med Physiol & Biochem, ZA-7505 Tygerberg, South Africa
关键词
p38; MAPK; ischaemic preconditioning; beta-adrenergic preconditioning; SB; 203580; functional recovery;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The stress kinase, p38 mitogen activated protein kinase (p38 MAPK), is known to be activated by both ischaemia and reperfusion. Whether this activation is beneficial or deleterious is still a matter of debate. The aims of this study were to (i) evaluate the activation pattern of p38 MAPK during a multi-cycle preconditioning protocol, during sustained (index) ischaemia and during reperfusion (ii) use transient beta-adrenergic stimulation to mimic ischaemic preconditioning and to study its effects on p38 MAPK activation and (iii) re-evaluate the effects of p38 MAPK blockade by SB 203580 on cardioprotection elicited by ischaernic preconditioning as well as by beta-adrenergic preconditioning. The isolated perfused working rat heart was subjected to a preconditioning protocol of 3 X 5 min global ischaemia or 5 min isoproterenol (10(-7) M) followed by 5min washout. All hearts were then subjected to 25min global ischaemia and 30min reperfusion during which time mechanical function was monitored. Hearts were freeze-clamped at different time intervals for subsequent analysis of p38 MAPK activation using Western blotting and a p38 MAPK phospho-antibody (Thr 180/Tyr 182). The results showed that p38 MAPK was activated transiently during a multi-cycle ischaernic preconditioning protocol and this was associated with attenuation of its kinase activity during both sustained ischaemia and reperfusion when compared with non-preconditioned hearts. beta-adrenergic preconditioning induced a similar pattern of attenuated p38 MAPK activation during sustained ischaemia and reperfusion. In all cases attenuation of p38 MAPK activation during ischaemia and reperfusion was associated with improved mechanical recovery during reperfusion. Using SB 203580 it was shown that p38 MAPK activation was not required as a trigger for ischaemic preconditioning, whereas it was a prerequisite for beta-adrenergic preconditioning. Conclusions: Attenuation of p38 MAPK activation during sustained ischaemia and reperfusion is always associated with improved functional recovery during reperfusion, indicating that activation of this kinase is detrimental to the ischaemic heart.
引用
收藏
页码:249 / 273
页数:25
相关论文
共 50 条
  • [1] Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion
    Marais, E
    Genade, S
    Huisamen, B
    Strijdom, JG
    Moolman, JA
    Lochner, A
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (04) : 769 - 778
  • [2] Activation of p38 MAPK is not a trigger for ischaemic preconditioning
    Genade, S
    Marais, E
    Moolman, J
    Lochner, A
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 : 244 - 244
  • [3] p38 MAPK activation: Trigger or mediator in ischaemic preconditioning (PC)?
    Lochner, A
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A70 - A70
  • [4] The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning
    Erna Marais
    Sonia Genade
    Ruduwaan Salie
    Barbara Huisamen
    Stefan Maritz
    Johan A. Moolman
    Amanda Lochner
    [J]. Basic Research in Cardiology, 2005, 100 : 35 - 47
  • [5] The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning
    Marais, E
    Genade, S
    Salie, R
    Huisamen, B
    Maritz, S
    Moolman, JA
    Lochner, A
    [J]. BASIC RESEARCH IN CARDIOLOGY, 2005, 100 (01) : 35 - 47
  • [6] T4 pretreatment and ischaemic preconditioning have additive cardioprotective effect possibly mediated by p38 MAPK attenuation during ischaemia
    Paizis, I
    Pantos, C
    Malliopoulou, V
    Karamanoli, E
    Moraitis, P
    Varonos, D
    Cokkinos, DV
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 : 219 - 219
  • [7] p38 MAPK activation triggers pharmacologically-induced β-adrenergic preconditioning, but not ischaemic preconditioning
    Marais, E
    Genade, S
    Strijdom, H
    Moolman, JA
    Lochner, A
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (12) : 2157 - 2177
  • [8] Ischaemic preconditioning and reperfusion: Study of the activation pattern of JNK and P38MAPK
    Moraitis, P
    Paizis, I
    Malliopoulou, V
    Mourouzis, I
    Tzeis, S
    Cokkinos, DD
    Pantos, C
    Varonos, D
    Cokkinos, DV
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (06) : A44 - A44
  • [9] Xenon-induced pharmacological preconditioning involves activation of p38 MAPK in vivo
    Weber, N. C.
    Toma, O.
    Wolter, J. I.
    Schlack, W.
    Preckel, B.
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 : 52 - 52
  • [10] Involvement of p38 MAPK in ischaemic preconditioning and thyroxine induced cardioprotection
    Paizis, I
    Malliopoulou, V
    Mourouzis, I
    Tzeis, S
    Cokkinos, DD
    Pantos, C
    Varonos, D
    Colkkinos, DV
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 : 294 - 294